GlassScriptPhysician profile
Preeti Yonker
NPI 1841409000
$23,695.19
in general payments reported to CMS, 2019-2025
58 companies · $3,911 in 2025
The $3,911 reported for 2025 was more than what 82% of Neurology (Psychiatry & Neurology) providers received nationally (typical 2025 total: $454).
See the full distribution for Neurology (Psychiatry & Neurology)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,683 · 2020: $2,185 · 2021: $3,497 · 2022: $3,364 · 2023: $3,365 · 2024: $3,690 · 2025: $3,911.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $11K · Education: $116.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $10,850.89 |
| Education | $115.96 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Teva Pharmaceuticals USA, INC. | $3,488.48 | 2019-2025 | Austedo Xr, Austedo Xr, Austedo |
| Biogen, INC. | $1,877.85 | 2019-2025 | Vumerity, Tysabri, Avonex |
| Ucb, INC. | $1,803.41 | 2019-2025 | Briviact, Fintepla, Rystiggo |
| Abbvie INC. | $1,455.84 | 2019-2025 | Botox, Ubrelvy, Duopa |
| Genentech USA, INC. | $1,281.68 | 2019-2025 | Ocrevus, Ocrevus Zunovo, Enspryng |
| Lilly USA, LLC | $1,101.52 | 2019-2025 | Emgality, Reyvow, Amyvid |
| Emd Serono, INC. | $1,073.38 | 2019-2025 | Mavenclad |
| Amgen INC. | $850.61 | 2019-2025 | Uplizna |
| Novartis Pharmaceuticals Corporation | $794.75 | 2019-2025 | |
| Neurocrine Biosciences, INC. | $746.42 | 2019-2025 | Ingrezza, Ongentys |
| Amneal Pharmaceuticals LLC | $681.42 | 2019-2025 | Rytary, Crexont, Ongentys 50mg Capsules 30 |
| Lundbeck LLC | $635.21 | 2019-2025 | Vyepti |
| Eisai INC. | $616.94 | 2019-2025 | |
| Acadia Pharmaceuticals INC | $605.83 | 2019-2025 | Nuplazid |
| Mallinckrodt Hospital Products INC. | $546.72 | 2020-2025 | Acthar |
Show all 58 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Preeti Yonker listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.